159 related articles for article (PubMed ID: 20367953)
1. [The effects of Tumstatin185-191 on lung adenocarcinoma cell lines and the association with protein kinase B and extracellular regulated protein kinase activation].
Wang W; Chen P; Li JL; Pei YF; Shuang QC; Liu CH; Cai S; Liu SK; Zhu LY; Zhou R
Zhonghua Jie He He Hu Xi Za Zhi; 2010 Feb; 33(2):123-7. PubMed ID: 20367953
[TBL] [Abstract][Full Text] [Related]
2. [Tumstatin185-191 increases the sensitivity to cisplatin in a cisplatin-resistant human lung adenocarcinoma cell line].
Wang W; Chen P; Li JL; Pei YF; Shuang QC; Liu CH; Cai S; Liu SK; Zhu LY; Zhou R
Zhonghua Zhong Liu Za Zhi; 2009 Aug; 31(8):577-81. PubMed ID: 20021943
[TBL] [Abstract][Full Text] [Related]
3. Depleted aldehyde dehydrogenase 1A1 (ALDH1A1) reverses cisplatin resistance of human lung adenocarcinoma cell A549/DDP.
Wei Y; Wu S; Xu W; Liang Y; Li Y; Zhao W; Wu J
Thorac Cancer; 2017 Jan; 8(1):26-32. PubMed ID: 27813328
[TBL] [Abstract][Full Text] [Related]
4. Effects of VBMDMP on the reversal of cisplatin resistance in human lung cancer A549/DDP cells.
Wang CK; Zhang Y; Zhang ZJ; Qiu QW; Cao JG; He ZM
Oncol Rep; 2015 Jan; 33(1):372-82. PubMed ID: 25394854
[TBL] [Abstract][Full Text] [Related]
5. Co-treatment with BEZ235 enhances chemosensitivity of A549/DDP cells to cisplatin via inhibition of PI3K/Akt/mTOR signaling and downregulation of ERCC1 expression.
Xia A; Li H; Li R; Lu L; Wu X
Oncol Rep; 2018 Oct; 40(4):2353-2362. PubMed ID: 30066933
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic effects of sorafenib on the A549/DDP human lung adenocarcinoma cell line in vitro.
Chen XQ; Wang YL; Li ZY; Lin TY
Mol Med Rep; 2014 Jul; 10(1):347-52. PubMed ID: 24788469
[TBL] [Abstract][Full Text] [Related]
7. [Effects of AS1411 on the apoptosis of taxol-resistant lung adenocarcinoma A549 cell].
Zhou W; Zhao Z; Liu L; Zhan Q; Song Y
Zhonghua Yi Xue Za Zhi; 2014 May; 94(18):1422-6. PubMed ID: 25142997
[TBL] [Abstract][Full Text] [Related]
8. Bisdemethoxycurcumin sensitizes cisplatin-resistant lung cancer cells to chemotherapy by inhibition of CA916798 and PI3K/AKT signaling.
Wang HJ; Yang ZX; Dai XT; Chen YF; Yang HP; Zhou XD
Apoptosis; 2017 Sep; 22(9):1157-1168. PubMed ID: 28677094
[TBL] [Abstract][Full Text] [Related]
9. [Small molecule inhibitor SB203580 enhances the antitumor effect of gefitinib in PC-9 and A549 lung cancer cell lines].
Zhao YM; Su B; Yang XJ; Shi JY; Tang L; Zhang J; Li JY; Chen J
Zhonghua Zhong Liu Za Zhi; 2013 Feb; 35(2):103-8. PubMed ID: 23714663
[TBL] [Abstract][Full Text] [Related]
10. Effects of p73 gene overexpression on apoptosis and chemosensitivity of human lung adenocarcinoma cell line A549.
He Y; Fan SZ; Jiang YG
Ai Zheng; 2006 Aug; 25(8):925-32. PubMed ID: 16965670
[TBL] [Abstract][Full Text] [Related]
11. [Effect of down-regulation of survivin gene on apoptosis and cisplatin resistance in cisplatin resistant human lung adenocarcinoma A549/CDDP cells].
Zhang MC; Hu CP; Chen Q
Zhonghua Zhong Liu Za Zhi; 2006 Jun; 28(6):408-12. PubMed ID: 17152483
[TBL] [Abstract][Full Text] [Related]
12. Combination treatment with triptolide and hydroxycamptothecin synergistically enhances apoptosis in A549 lung adenocarcinoma cells through PP2A-regulated ERK, p38 MAPKs and Akt signaling pathways.
Meng G; Wang W; Chai K; Yang S; Li F; Jiang K
Int J Oncol; 2015 Mar; 46(3):1007-17. PubMed ID: 25573072
[TBL] [Abstract][Full Text] [Related]
13. Involvement of ROS in the inhibitory effect of thermotherapy combined with chemotherapy on A549 human lung adenocarcinoma cell growth through the Akt pathway.
Wang L; Liu X; Wu Y; Wu W; Wu Y
Oncol Rep; 2012 Oct; 28(4):1369-75. PubMed ID: 22895800
[TBL] [Abstract][Full Text] [Related]
14. CNTN-1 Enhances Chemoresistance in Human Lung Adenocarcinoma Through Induction of Epithelial-Mesenchymal Transition by Targeting the PI3K/Akt Pathway.
Zhang R; Sun S; Ji F; Liu C; Lin H; Xie L; Yang H; Tang W; Zhou Y; Xu J; Li P
Cell Physiol Biochem; 2017; 43(2):465-480. PubMed ID: 28934754
[TBL] [Abstract][Full Text] [Related]
15. TAZ inhibition restores sensitivity of cisplatin via AKT/mTOR signaling in lung adenocarcinoma.
Xu W; Wei Y; Li Y; Yin Y; Yuan W; Yang Y; Zhao W; Wu J
Oncol Rep; 2017 Sep; 38(3):1815-1821. PubMed ID: 28737828
[TBL] [Abstract][Full Text] [Related]
16. Apatinib resensitizes cisplatin-resistant non-small cell lung carcinoma A549 cell through reversing multidrug resistance and suppressing ERK signaling pathway.
Liu ZL; Jin BJ; Cheng CG; Zhang FX; Wang SW; Wang Y; Wu B
Eur Rev Med Pharmacol Sci; 2017 Dec; 21(23):5370-5377. PubMed ID: 29243778
[TBL] [Abstract][Full Text] [Related]
17. [Combined inhibition of PI3K and MEK has synergistic inhibitory effect on the proliferation of cisplatin-resistant ovarian cancer cells].
Liu Y; Chen X; Luo Z
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Jun; 30(6):592-6. PubMed ID: 24909280
[TBL] [Abstract][Full Text] [Related]
18. [The roles of holothurian glycosaminoglycan combined with cisplatin on proliferation and chemotherapeutic response in A549 human lung adenocarcinoma cell].
Jin Q; Zhu XH; Lin CZ; Zhang H; Cao YW; Ding XQ; Lyu ZH
Zhonghua Zhong Liu Za Zhi; 2018 Apr; 40(4):252-257. PubMed ID: 29730910
[No Abstract] [Full Text] [Related]
19. C-Myc participates in β-catenin-mediated drug resistance in A549/DDP lung adenocarcinoma cells.
Xie C; Pan Y; Hao F; Gao Y; Liu Z; Zhang X; Xie L; Jiang G; Li Q; Wang E
APMIS; 2014 Dec; 122(12):1251-8. PubMed ID: 25131138
[TBL] [Abstract][Full Text] [Related]
20. [Effects of trichostatin A on human lung cancer cell strains A549].
Zhang D; Liu CT; Yu XD; Liu Y
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2010 Apr; 32(2):167-70. PubMed ID: 20450546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
